Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,657 followers.

RT @FrontOncology: New research: Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different cl…

12 Aug 2023

Reply Repost Favourite

New research: Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy: Introduction Rituximab (R), an anti-CD20 monoclonal antibody (mAb) and the world’s first approved… #oncology htt

12 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.